文献速递创伤骨科关节外科

老年患者髋臼骨折干预试验(AceFIT):一项可行性三臂随机对照研究

Acetabular Fractures in older patients Intervention Trial (AceFIT): a feasibility triple-arm randomized controlled study.
PubMed 文献 · Bone Joint J · 2024-04-01

AceFIT 是一项在 7 个英国 NHS 中心开展的三臂预试验,纳入 60 例年龄大于 60 岁的移位性髋臼骨折患者,比较手术固定、手术固定联合髋关节置换(fix-and-replace)与非手术治疗三种方案。研究显示开展完整规模随机对照试验可行,但需国际招募;试验为一项跨国随机对照试验的样本量设计提供了依据,样本量为 1,474 例或 1,974 例,对应 EQ-5D 最小临床重要差异 0.06、把握度 0.8 或 0.9、失访率 20%。

要点

  • 7 个英国 NHS 中心在 2017 年 12 月至 2019 年 12 月共招募 60 例患者(中位年龄 77.4 岁,范围 63.3 至 88.5;男/女比为 39/21)。
  • 九个月最终随访时 4/60(7%)退出、4/60(7%)死亡、1 例失访;EQ-5D 问卷应答率为 98%(50/51)。
  • 三年试验期间共记录 4 例死亡:非手术治疗组 3 例,fix-and-replace 组 1 例。

核心结论

  • 本研究表明开展完整规模随机对照试验是可行的,但将需要国际招募。
  • AceFIT 为跨国随机对照试验的样本量设计提供了依据:样本量为 1,474 例或 1,974 例,对应 EQ-5D 最小临床重要差异 0.06、把握度 0.8 或 0.9、失访率 20%。
  • 观察到的患者队列属于医学上复杂、需要多学科照护的群体,需要外科医生、麻醉医生和骨科老年医学医生的参与以优化康复与功能恢复。

研究设计与样本

  • 三臂预试验随机对照研究,患者来自 7 个英国 NHS 中心,年龄大于 60 岁且为移位性髋臼骨折。
  • 可行性结局包括患者参与意愿、临床医生招募能力和退出率;主要临床结局指标为六个月时的欧洲五维健康量表(EQ-5D)。
  • 次要结局包括牛津髋关节评分、残疾评定量表、失血量以及影像学和活动能力评估。

主要发现

  • 2017 年 12 月至 2019 年 12 月共招募 60 例患者,中位年龄 77.4 岁(范围 63.3 至 88.5),男/女比为 39/21。
  • 九个月最终随访时,4/60(7%)退出、4/60(7%)死亡、1 例失访;EQ-5D 问卷应答率为 98%(50/51)。
  • 三年试验期间共记录 4 例死亡:非手术治疗组 3 例,fix-and-replace 组 1 例。

关键数值与推荐

  • EQ-5D 最小临床重要差异为 0.06。
  • 跨国随机对照试验样本量为 1,474 例或 1,974 例,对应把握度 0.8 或 0.9,失访率 20%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To assess the feasibility of a randomized controlled trial (RCT) that compares three treatments for acetabular fractures in older patients: surgical fixation, surgical fixation and hip arthroplasty (fix-and-replace), and non-surgical treatment. METHODS: Patients were recruited from seven UK NHS centres and randomized to a three-arm pilot trial if aged older than 60 years and had a displaced acetabular fracture. Feasibility outcomes included patients' willingness to participate, clinicians' capability to recruit, and dropout rates. The primary clinical outcome measure was the EuroQol five-dimension questionnaire (EQ-5D) at six months. Secondary outcomes were Oxford Hip Score, Disability Rating Index, blood loss, and radiological and mobility assessments. RESULTS: Between December 2017 and December 2019, 60 patients were recruited (median age 77.4 years, range 63.3 to 88.5) (39/21 M/F ratio). At final nine-month follow-up, 4/60 (7%) had withdrawn, 4/60 (7%) had died, and one had been lost to follow-up; a 98% response rate (50/51) was achieved for the EQ-5D questionnaire. Four deaths were recorded during the three-year trial period: three in the non-surgical treatment group and one in the fix-and-replace group. CONCLUSION: This study has shown a full-scale RCT to be feasible, but will need international recruitment. The Acetabular Fractures in older patients Intervention Trial (AceFIT) has informed the design of a multinational RCT sample size of 1,474 or 1,974 patients for a minimal clinically important difference of 0.06 on EQ-5D, with a power of 0.8 or 0.9, and loss to follow-up of 20%. This observed patient cohort comprises a medically complex group requiring multidisciplinary care; surgeon, anaesthetist, and ortho-geriatrician input is needed to optimize recovery and rehabilitation.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Carrothers A, O'Leary R, Hull P, et al. Acetabular Fractures in older patients Intervention Trial (AceFIT): a feasibility triple-arm randomized controlled study. Bone Joint J. 2024. PMID: 38555939. doi:10.1302/0301-620X.106B4.BJJ-2023-1080.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。